Meditrina

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$344Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
4,024clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1,371
2020 $1,161
2021 $55K
2022 $109K
2023 $84K
2024 $28K
2025 $66K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Obstetrics & Gynecology $247K
Gynecology $29K
Urogynecology and Reconstructive Pelvic Surgery (Urology) $27K
Gynecologic Oncology $17K
Obstetrics $6,789
Reproductive Endocrinology $3,926

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Geoffrey Bowers Voorhees, NJ Obstetrics & Gynecology $34,800.00
Andrew Brill San Francisco, CA Urogynecology and Reconstructive Pelvic Surgery (Urology) $27,250.00
Valentin Almendarez San Antonio, TX Obstetrics & Gynecology $27,100.00
Amy Garcia Albuquerque, NM Gynecology $22,738.01
Zoyla Almeida Coconut Creek, FL Gynecologic Oncology $13,715.21
Jason Sternchos Manhasset, NY Obstetrics & Gynecology $9,868.85
Peter Khamvongsa Miami, FL Obstetrics & Gynecology $9,821.06
Jay Fisher West Bloomfield, MI Obstetrics & Gynecology $6,761.78
Danielle Shiller Baltimore, MD Obstetrics & Gynecology $6,340.86
Gerard Reilly Cincinnati, OH Obstetrics & Gynecology $5,865.86

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.